Correlation Between Amicus Therapeutics and Prestige Brand

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Amicus Therapeutics and Prestige Brand at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amicus Therapeutics and Prestige Brand into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Amicus Therapeutics and Prestige Brand Holdings, you can compare the effects of market volatilities on Amicus Therapeutics and Prestige Brand and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amicus Therapeutics with a short position of Prestige Brand. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amicus Therapeutics and Prestige Brand.

Diversification Opportunities for Amicus Therapeutics and Prestige Brand

-0.46
  Correlation Coefficient

Very good diversification

The 3 months correlation between Amicus and Prestige is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Amicus Therapeutics and Prestige Brand Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Prestige Brand Holdings and Amicus Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amicus Therapeutics are associated (or correlated) with Prestige Brand. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Prestige Brand Holdings has no effect on the direction of Amicus Therapeutics i.e., Amicus Therapeutics and Prestige Brand go up and down completely randomly.

Pair Corralation between Amicus Therapeutics and Prestige Brand

Given the investment horizon of 90 days Amicus Therapeutics is expected to under-perform the Prestige Brand. But the stock apears to be less risky and, when comparing its historical volatility, Amicus Therapeutics is 1.36 times less risky than Prestige Brand. The stock trades about -0.1 of its potential returns per unit of risk. The Prestige Brand Holdings is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  7,738  in Prestige Brand Holdings on December 29, 2024 and sell it today you would earn a total of  866.00  from holding Prestige Brand Holdings or generate 11.19% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Amicus Therapeutics  vs.  Prestige Brand Holdings

 Performance 
       Timeline  
Amicus Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Amicus Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's essential indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
Prestige Brand Holdings 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Prestige Brand Holdings are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite fairly unfluctuating fundamental drivers, Prestige Brand may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Amicus Therapeutics and Prestige Brand Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Amicus Therapeutics and Prestige Brand

The main advantage of trading using opposite Amicus Therapeutics and Prestige Brand positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amicus Therapeutics position performs unexpectedly, Prestige Brand can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Prestige Brand will offset losses from the drop in Prestige Brand's long position.
The idea behind Amicus Therapeutics and Prestige Brand Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk